Screening for colorectal cancer, 1996.
Screening average-risk people aged 55 to 70 years for colorectal cancer is now a public health priority in Australia. Pilot studies of faecal occult blood testing are required to find ways of achieving optimal compliance and cost efficiency in the Australian health care setting. Flexible sigmoidoscopy probably should be used as complementary screening but further trials are needed. High-risk groups (family history of colorectal cancer, or previous ulcerative colitis, adenomas or cancer) should already be in surveillance programs.
Macrae
F A
FA
Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, VIC.
D011125:Adenomatous Polyposis Coli / Q000453:epidemiology; D018256:Adenomatous Polyps / Q000453:epidemiology; D000368:Aged; D001315:Australia / Q000453:epidemiology; D016022:Case-Control Studies; D003093:Colitis, Ulcerative / Q000453:epidemiology; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods; D008875:Middle Aged; D009780:Occult Blood; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012812:Sigmoidoscopy